G
GRAINPAD Private
AI-powered virtual physician and healthcare chatbot services
About GRAINPAD Private
GRAINPAD Private Limited is a research and innovation company operating in the health-tech sector, leveraging artificial intelligence, machine learning, and robotics. Founded in 2017 by Dr. Rohit Sharma and Raj Kumar Sehgal, the Delhi-based startup aims to make quality medical advice accessible and affordable. Dr. Sharma, a qualified physician, was motivated to start the company after observing that many people in India lacked access to reliable medical information, often relying on unlicensed practitioners.
The company's flagship product is ZINI, an AI-driven, voice-based virtual physician. This medical chatbot can conduct a full diagnostic interview based on initial symptoms, ask relevant follow-up questions, and provide a preliminary diagnosis. ZINI also suggests the urgency of the situation, the type of specialist needed, and available treatment options. The technology is designed to be integrated into hospital and clinic apps and websites (B2B) or used directly by consumers (B2C). For B2B clients, it serves to automate patient history collection and organize information for doctors. The B2C model offers a certain number of free evaluations before moving to a subscription plan. The company's clients include hospitals and telehealth platforms in India, the UAE, and the United States.
Beyond ZINI, GRAINPAD offers B2B services including data analytics, automation solutions, and chatbot design and integration. The company is also developing other products, such as TOBI, an autonomous logistics robot for warehouses, and Project ROBODOC, which will use medical sensors and computer vision to perform basic physical examinations. The company raised an undisclosed seed funding amount in November 2021.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Noida, India
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sector
- Health, DNA, Genetics and genomics, Health Diagnostics, Physician Support Tools, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Nov 2021 | $14M | $55M | Undisclosed | ↗ |
| GRANT✓Other financing | 2021 | $400K | — | Undisclosed | — |
Growth signals
Latest recorded traffic for GRAINPAD Private is 570 monthly website visits, up 185% over the last three months. GRAINPAD Private's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GRAINPAD Private on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GRAINPAD Private’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






